查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2002811

医用注射射出成型塑胶市场：2026-2032年全球市场预测（依产品类型、材料类型、应用、製造流程和无菌要求划分）

Medical Injection Molded Plastics Market by Product Type, Material Type, End Use, Process Type, Sterility Requirement - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医用射出成型塑胶市场价值将达到 662.4 亿美元，到 2026 年将成长至 715 亿美元，到 2032 年将达到 1,206.8 亿美元，复合年增长率为 8.94%。

主要市场统计数据
基准年 2025 662.4亿美元
预计年份：2026年 715亿美元
预测年份 2032 1206.8亿美元
复合年增长率 (%) 8.94%

对医用射出成型塑胶市场进行全面概述，重点在于精密製造、法规遵循和业务永续营运。

医用射出成型塑胶产业融合了精密工程、严格的法规和临床需求。製造商和供应商必须在复杂的供应商生态系统中游刃有余，同时还要兼顾材料科学的进步、严格的洁净度标准和不断发展的医疗设备设计，并积极响应日益增长的患者安全和医疗设备可靠性需求。

技术进步、更严格的法规和以患者主导的设计如何影响医用塑胶的生产要求和竞争优势？

受技术进步、法规和终端用户趋势的驱动，医用射出成型塑胶产业正经历着变革性的转变。聚合物配方和积层製造（AM）相容树脂的进步，使得生产更轻、更耐用的零件成为可能，并促进了射出成型与微加工技术相结合的混合生产策略的实施。

评估 2025 年美国关税调整及其对供应链结构、材料筹资策略和业务永续营运。

美国于2025年征收的关税的累积影响波及整个医疗射出成型供应链。在报復性关税和贸易政策转变影响原料流通的地区，某些聚合物等级和特殊添加剂的投入成本增加，迫使采购团队重新评估筹资策略和供应商选择。

透过对产品、材料、最终用途、製程和无菌性等维度进行综合細項分析，可以揭示技术重点和商业化限制。

市场区隔洞察揭示了产品、材料、最终用途、製程和无菌要求等方面的技术复杂性与商业性机会的交会点。按产品类型划分，市场涵盖诊断组件、给药系统、输液器、实验室设备、手术器械和注射器。诊断组件包括加盖和加压盖、比色皿、微孔盘和微量吸管尖。给药系统包括自动注射器、吸入器和笔式註射器。输液器包括延长管、PCA输液器和标准输液器。实验室设备包括烧杯、烧瓶、培养皿和试管。手术器械包括套管、钳子、镊子和牵开器。注射器包括预填充式注射器、安全注射器和标准注射器。每类产品都有不同的公差、表面光洁度和可追溯性要求，而给药装置和手术器械通常需要更高的尺寸控制和无菌保证。

影响製造地和打入市场策略的美洲、欧洲、中东和非洲以及亚太地区的区域生产和监管趋势。

在美洲、欧洲、中东和非洲以及亚太地区，区域趋势正在影响生产基地选择、供应商选择和监管合规的策略决策。在美洲，接近性关键医疗系统和拥有快速反应的物流基础设施仍然至关重要，这促使企业投资建设本地生产基地并进行国内验证，以支持对时间要求严格的产品上市。

在医用塑胶领域，企业间的策略性投资、伙伴关係和能力差异化如何决定竞争地位和供应可靠性？

射出成型医用塑胶产业的企业策略体现了能力建构、垂直整合和策略伙伴关係之间的平衡。领先的製造商在无尘室基础设施、精密模具和线上检测系统方面投入巨资，以满足复杂的产品组装和严格的无菌要求。同时，小规模的专业公司则透过提供微成型技术和快速原型製作，为早期医疗设备开发开拓利基市场。

产业领导者为加强医疗设备组件的供应韧性、加快验证速度和提高製造弹性所提出的实际策略重点。

产业领导者应优先投资于能够增强供应链韧性、缩短验证週期并提高生产柔软性。关键聚合物供应商多元化以及确保区域树脂缓衝供应可以减轻贸易中断的影响。此外，对替代材料进行并行认证可以为设计团队提供应急方案，而不会影响设备性能。

结合专家访谈、实地检验审查和文献整合的稳健混合研究途径，确保了可操作和可靠的见解。

本分析的调查方法结合了对技术文献、监管指南和行业最佳实践的系统性回顾，以及定性访谈和现场观察。主要资讯来源包括对製造工程师、品质经理和采购主管的专家访谈，以及工厂现场考察和验证通讯协定审查，以评估实际实施中面临的挑战。

整合策略挑战，强调为什么对材料、过程控制和供应商韧性的投资对于长期竞争力至关重要。

医疗射出成型塑胶产业面临着技术日益复杂、监管力度不断加强以及供应链形势瞬息万变等诸多挑战——所有这些因素都要求企业采取谨慎的策略行动。投资于材料合格流程、无尘室设施和数位化流程控制的企业，将更有能力应对以病人主导的设计趋势和日益严格的验证要求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 医用射出成型塑胶市场：依产品类型划分

  • 诊断组件
    • 封顶尖峰帽
    • 库维特
    • 微孔盘
    • 微量吸管尖
  • 药物输送系统
    • 自动注射器
    • 吸入器
    • 笔式註射器
  • 点滴器
    • 扩充集
    • PCA套装
    • 标准静脉输液套装
  • 实验室设备
    • 烧杯
    • 烧瓶
    • 培养皿
    • 试管
  • 手术器械
    • 套管
    • 夹钳
    • 钳子
    • 牵开器
  • 注射器
    • 预填充式注射器
    • 安全注射器
    • 标准注射器

第九章 医用射出成型塑胶市场：依材料类型划分

  • ABS
  • 聚碳酸酯
  • 聚乙烯
    • HDPE
    • LDPE
  • 聚丙烯
  • 聚苯乙烯

第十章 医用射出成型塑胶市场：依最终用途划分

  • 诊所
  • 诊断检查室
  • 居家医疗
  • 医院
  • 製药公司

第十一章：依工艺分類的医用射出成型塑胶市场

  • 洁净室模具
    • 七年级
    • 八年级
  • 传统射出成型
  • 微型射出成型
  • 多色射出成型

第十二章：依灭菌要求分類的医用射出成型塑胶市场

  • 非无菌部件
  • 无菌部件

第十三章 医用射出成型塑胶市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 医用射出成型塑胶市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 医用射出成型塑胶市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医用射出成型塑胶市场

第十七章：中国医用射出成型塑胶市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AMS Micromedical LLC
  • AptarGroup, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Berry Global, Inc.
  • C&J Industries, Inc.
  • Currier Plastics, Inc.
  • Engel Austria GmbH
  • Freudenberg Medical LLC
  • Gerresheimer AG
  • Harbec, Inc.
  • HTI Plastics
  • Jabil Healthcare
  • MedPlast, Inc.
  • Metro Mold & Design, Inc.
  • Milacron Holdings Corp.
  • Nipro Corporation
  • Rochling SE & Co. KG
  • SCHOTT AG
  • SMC Ltd.
  • Spectrum Plastics Group, Inc.
  • Stevanato Group SpA
  • Tekni-Plex, Inc.
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.
Product Code: MRR-7C50F2739303

The Medical Injection Molded Plastics Market was valued at USD 66.24 billion in 2025 and is projected to grow to USD 71.50 billion in 2026, with a CAGR of 8.94%, reaching USD 120.68 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 66.24 billion
Estimated Year [2026] USD 71.50 billion
Forecast Year [2032] USD 120.68 billion
CAGR (%) 8.94%

A comprehensive orientation to the medical injection-molded plastics landscape emphasizing precision manufacturing, regulatory compliance, and operational resilience

The medical injection-molded plastics sector operates at the intersection of precision engineering, regulatory rigor, and clinical necessity. Manufacturers and suppliers must reconcile material science advances with stringent cleanliness standards and evolving device designs, while navigating complex supplier ecosystems and increasing emphasis on patient safety and device reliability.

Recent years have seen intensified attention on process repeatability, material traceability, and sterility management, prompting stakeholders to reassess capital deployment, quality systems, and strategic partnerships. As companies innovate across product portfolios, they must also balance speed-to-market with validation burdens, making operational excellence and regulatory foresight central to sustained competitiveness.

How converging technological advances, regulatory tightening, and patient-driven design are reshaping production imperatives and competitive advantage in medical plastics

The landscape for injection-molded medical plastics is undergoing transformative shifts driven by technological, regulatory, and end-user trends. Advances in polymer formulations and additive manufacturing-compatible resins are enabling lighter, more durable components and facilitating hybrid production strategies that blend injection molding with microfabrication techniques.

Concurrently, regulatory authorities are tightening device validation pathways and demanding greater supply chain transparency, which in turn elevates the importance of cleanroom capabilities and validated sterilization workflows. Patient-centric design is reshaping product specifications, pushing manufacturers toward modular drug delivery systems and integrated diagnostics that require higher dimensional accuracy and biocompatibility. These converging changes necessitate investments in automation, in-line inspection, and data-driven process control to maintain throughput while ensuring consistent quality.

Assessment of the 2025 United States tariff adjustments and their cascading effects on supply chain configurations, material sourcing strategies, and operational resilience

The cumulative effects of tariffs introduced by the United States in 2025 ripple across the supply chains that underpin medical injection molding. Input costs for certain polymer grades and specialized additives rose in jurisdictions where reciprocal tariffs and trade policy shifts affected raw material flows, prompting procurement teams to re-evaluate sourcing strategies and vendor footprints.

In response, some manufacturers accelerated supplier diversification and nearshoring initiatives, investing in regional resin inventories and alternative material qualification programs to mitigate single-source exposure. These adjustments introduced short-term operational overheads but also stimulated longer-term reconfiguration of logistics and inventory strategies, the outcome of which has been greater emphasis on supplier resilience and localized validation capabilities to preserve regulatory compliance while stabilizing production costs.

Integrated segmentation analysis across product, material, end-use, process, and sterility axes to reveal technical priorities and commercialization constraints

Segmentation insights reveal where technical complexity and commercial opportunity intersect across product, material, end use, process, and sterility requirements. Based on Product Type, the market encompasses Diagnostic Components, Drug Delivery Systems, Infusion Sets, Labware, Surgical Instruments, and Syringes; Diagnostic Components further include Capping Spiking Caps, Cuvettes, Microplates, and Pipette Tips; Drug Delivery Systems further include Autoinjectors, Inhalers, and Pen Injectors; Infusion Sets further include Extension Sets, Pca Sets, and Standard Infusion Sets; Labware further includes Beakers, Flasks, Petri Dishes, and Test Tubes; Surgical Instruments further include Cannulas, Clamps, Forceps, and Retractors; Syringes further include Prefilled Syringes, Safety Syringes, and Standard Syringes. Each product cluster imposes distinct tolerances, surface finishes, and traceability requirements, with drug delivery devices and surgical instruments typically demanding higher levels of dimensional control and sterility assurance.

Based on Material Type, critical polymers include ABS, Polycarbonate, Polyethylene, Polypropylene, and Polystyrene, with Polyethylene further differentiated into HDPE and LDPE. Material selection drives decisions around sterilization compatibility, biocompatibility testing, and long-term stability, while also determining tool wear and cycle times. Based on End Use, components serve Clinics, Diagnostic Labs, Home Healthcare settings, Hospitals, and Pharmaceutical Companies, and each end-use environment imposes unique packaging, labeling, and usability constraints that influence design and process choices. Based on Process Type, production techniques range from Cleanroom Molding, Conventional Injection Molding, Micro Injection Molding, to Multi-Shot Injection Molding, with Cleanroom Molding further classified into Class 7 and Class 8 environments; process choice affects contamination risk, inspection regimes, and cleanroom utilities. Finally, based on Sterility Requirement, differentiation between Non-Sterile Components and Sterile Components informs material handling, validation depth, and post-molding sterilization workflow design.

Taken together, these segmentation layers illustrate that cross-functional coordination between design engineering, materials science, and quality assurance is essential. Manufacturers must align polymer selection with molding capabilities and end-use demands while ensuring that process classification and sterility pathways are validated early in development to avoid rework and regulatory delays.

Regional production and regulatory dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence manufacturing footprint and market access strategies

Regional dynamics shape strategic choices for production location, supplier selection, and regulatory navigation across the Americas, Europe, Middle East & Africa, and Asia-Pacific. The Americas region continues to emphasize proximity to major healthcare systems and rapid response logistics, driving investments in localized manufacturing cells and onshore validation to support time-sensitive product launches.

In Europe, Middle East & Africa, regulatory harmonization and diverse market access requirements necessitate robust compliance frameworks and adaptable distribution models, with manufacturers prioritizing certifications and multilingual packaging. The Asia-Pacific region remains a pivotal source of polymer feedstocks and scale manufacturing capacity, prompting many organizations to maintain dual-location strategies that balance cost efficiency with redundancy. Collectively, these regional considerations underscore the importance of aligning manufacturing footprints with regulatory timelines, clinical trial schedules, and customer service expectations.

How strategic investments, partnerships, and capability differentiation among companies determine competitive positioning and supply reliability in the medical plastics domain

Company strategies in the injection-molded medical plastics space reflect a balance between capability development, vertical integration, and strategic partnerships. Market-leading manufacturers invest heavily in cleanroom infrastructure, precision tooling, and in-line inspection systems to support complex product assemblies and stringent sterility requirements, while smaller specialized firms carve niches by offering micro-molding expertise or rapid prototyping for early-stage device development.

Collaborative relationships between polymer suppliers, contract manufacturers, and device OEMs are increasingly common as organizations seek to compress development timelines and mitigate validation risks. Joint development agreements and co-investment in tooling or process automation are typical approaches to share capital risk and accelerate time-to-clinic. Additionally, quality certifications, audit track records, and the ability to provide comprehensive design-for-manufacturability feedback are among the primary differentiators that procurement teams evaluate when selecting partners.

Actionable strategic priorities for industry leaders to enhance supply resilience, accelerate validation, and improve manufacturing agility for medical device components

Industry leaders should prioritize investments that strengthen supply chain resilience, reduce validation cycle times, and increase manufacturing flexibility. Enhancing supplier diversification for critical polymers and establishing regional resin buffers can lower exposure to trade disruptions, while parallel qualification of alternative materials can provide design teams with contingency options without compromising device performance.

Operational improvements such as adopting in-line inspection, statistical process control, and automated documentation systems will compress time-to-release and reduce human error. Leaders should also evaluate opportunities to modularize product designs for easier assembly and sterilization, and to invest in cross-functional teams that integrate regulatory, quality, and manufacturing expertise early in development to avoid late-stage changes that are costly and time-consuming.

Robust mixed-methods research approach combining expert interviews, on-site validation reviews, and literature synthesis to ensure actionable and reliable insights

The research methodology underpinning this analysis combined a structured review of technical literature, regulatory guidance, and industry best practices with qualitative interviews and site-level observations. Primary inputs included expert interviews with manufacturing engineers, quality leaders, and procurement executives, supplemented by factory-floor walkthroughs and validation protocol reviews to assess practical implementation challenges.

Secondary inputs comprised peer-reviewed materials science publications, standards documentation, and publicly available regulatory notices that informed the interpretation of sterility, biocompatibility, and cleanroom requirements. Where possible, triangulation across multiple independent sources was used to corroborate observations and minimize single-source bias, and findings were synthesized to emphasize operational applicability and risk mitigation strategies for stakeholders.

Synthesis of strategic imperatives highlighting why investment in materials, process control, and supplier resilience is essential for long-term competitiveness

The medical injection-molded plastics sector is characterized by accelerating technical complexity, heightened regulatory scrutiny, and evolving supply chain realities that together demand deliberate strategic action. Organizations that invest in material qualification pathways, cleanroom capabilities, and digital process control will be better positioned to respond to patient-driven design trends and tighter validation expectations.

Moving forward, successful participants will be those that integrate cross-functional teams early in the development lifecycle, prioritize supplier resilience, and adopt targeted automation that enhances repeatability without sacrificing flexibility. By aligning technical investments with regulatory and regional market realities, manufacturers can convert current challenges into competitive advantage and sustainably support the healthcare products that depend on precision polymer components.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Injection Molded Plastics Market, by Product Type

  • 8.1. Diagnostic Components
    • 8.1.1. Capping Spiking Caps
    • 8.1.2. Cuvettes
    • 8.1.3. Microplates
    • 8.1.4. Pipette Tips
  • 8.2. Drug Delivery Systems
    • 8.2.1. Autoinjectors
    • 8.2.2. Inhalers
    • 8.2.3. Pen Injectors
  • 8.3. Infusion Sets
    • 8.3.1. Extension Sets
    • 8.3.2. Pca Sets
    • 8.3.3. Standard Infusion Sets
  • 8.4. Labware
    • 8.4.1. Beakers
    • 8.4.2. Flasks
    • 8.4.3. Petri Dishes
    • 8.4.4. Test Tubes
  • 8.5. Surgical Instruments
    • 8.5.1. Cannulas
    • 8.5.2. Clamps
    • 8.5.3. Forceps
    • 8.5.4. Retractors
  • 8.6. Syringes
    • 8.6.1. Prefilled Syringes
    • 8.6.2. Safety Syringes
    • 8.6.3. Standard Syringes

9. Medical Injection Molded Plastics Market, by Material Type

  • 9.1. Abs
  • 9.2. Polycarbonate
  • 9.3. Polyethylene
    • 9.3.1. Hdpe
    • 9.3.2. Ldpe
  • 9.4. Polypropylene
  • 9.5. Polystyrene

10. Medical Injection Molded Plastics Market, by End Use

  • 10.1. Clinic
  • 10.2. Diagnostic Labs
  • 10.3. Home Healthcare
  • 10.4. Hospitals
  • 10.5. Pharmaceutical Companies

11. Medical Injection Molded Plastics Market, by Process Type

  • 11.1. Cleanroom Molding
    • 11.1.1. Class 7
    • 11.1.2. Class 8
  • 11.2. Conventional Injection Molding
  • 11.3. Micro Injection Molding
  • 11.4. Multi-Shot Injection Molding

12. Medical Injection Molded Plastics Market, by Sterility Requirement

  • 12.1. Non-Sterile Components
  • 12.2. Sterile Components

13. Medical Injection Molded Plastics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Injection Molded Plastics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Injection Molded Plastics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Injection Molded Plastics Market

17. China Medical Injection Molded Plastics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AMS Micromedical LLC
  • 18.6. AptarGroup, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Becton, Dickinson and Company
  • 18.9. Berry Global, Inc.
  • 18.10. C&J Industries, Inc.
  • 18.11. Currier Plastics, Inc.
  • 18.12. Engel Austria GmbH
  • 18.13. Freudenberg Medical LLC
  • 18.14. Gerresheimer AG
  • 18.15. Harbec, Inc.
  • 18.16. HTI Plastics
  • 18.17. Jabil Healthcare
  • 18.18. MedPlast, Inc.
  • 18.19. Metro Mold & Design, Inc.
  • 18.20. Milacron Holdings Corp.
  • 18.21. Nipro Corporation
  • 18.22. Rochling SE & Co. KG
  • 18.23. SCHOTT AG
  • 18.24. SMC Ltd.
  • 18.25. Spectrum Plastics Group, Inc.
  • 18.26. Stevanato Group S.p.A.
  • 18.27. Tekni-Plex, Inc.
  • 18.28. Terumo Corporation
  • 18.29. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CAPPING SPIKING CAPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CAPPING SPIKING CAPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CAPPING SPIKING CAPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CUVETTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CUVETTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CUVETTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICROPLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICROPLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PIPETTE TIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PIPETTE TIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PIPETTE TIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY AUTOINJECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY AUTOINJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INHALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INHALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PEN INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PEN INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY EXTENSION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY EXTENSION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY EXTENSION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PCA SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PCA SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PCA SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD INFUSION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD INFUSION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD INFUSION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY BEAKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY BEAKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY BEAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FLASKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FLASKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FLASKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PETRI DISHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PETRI DISHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PETRI DISHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY TEST TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY TEST TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY TEST TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CANNULAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CANNULAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CANNULAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLAMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLAMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLAMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FORCEPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FORCEPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY FORCEPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY RETRACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY RETRACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SAFETY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SAFETY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SAFETY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STANDARD SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY ABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY ABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY ABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HDPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HDPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HDPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LDPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LDPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LDPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYSTYRENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYSTYRENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYSTYRENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 7, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 7, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 7, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 8, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 8, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLASS 8, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CONVENTIONAL INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CONVENTIONAL INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CONVENTIONAL INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICRO INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICRO INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MICRO INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MULTI-SHOT INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MULTI-SHOT INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MULTI-SHOT INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY NON-STERILE COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY NON-STERILE COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY NON-STERILE COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILE COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILE COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILE COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY INFUSION SETS, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY LABWARE, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY SYRINGES, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY CLEANROOM MOLDING, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY STERILITY REQUIREMENT, 2018-2032 (USD MILLION)
  • TABLE 284. GCC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. GCC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. GCC MEDICAL INJECTION MOLDED PLASTICS MARKET SIZE, BY DIAGNOSTIC COMPONENTS